Skip to main content

DAXOR CORP

corporate_fare Company Profile

DAXOR CORP

DXR·NASDAQ·Unknown·CIK 0000027367

Daxor Corporation is a medical device manufacturing company that also provides biotechnology services. The company was originally incorporated in New York State in May 1971 as Iatric Corporation, providing cryobanking services. This service continues through its wholly-owned subsidiary, Scientific Medical Systems. The company's name changed to Idant Corporation in October 1971, and then to Daxor Corporation in May 1973. Its principal executive offices are located at 350 Fifth Avenue, Suite 7120, New York, NY 10118. For the past 16 years, Daxor Corporation has primarily focused on the BVA-100 ® Blood Volume Analyzer, an instrument designed to rapidly and accurately measure human blood volume. This instrument is used with Volumex ® , a single-use radiopharmaceutical diagnostic injection and collection kit. The company also offers cryobanking services for blood storage through Scientific Medical Systems and for semen storage through Idant, a subsidiary of Scientific Medical Systems. Daxor Corporation owns the Daxor Oak Ridge Operations (DORO) facility in Oak Ridge, TN, which is responsible for manufacturing, testing, and developing next-generation models of the BVA-100 ® .

DAXOR CORP (NASDAQ:DXR) is a publicly traded company in the Unknown sector. Wiseek monitors DXR SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Daxor Wins Patent for Remote Blood Volume Monitor, Expanding Diagnostic Capabilities
  • Daxor Seeks Deregistration as Investment Company, Gaining Operational & Capital Flexibility
  • Daxor Launches New BVA Program at High-Volume Ohio Cardiology Center, Boosting Customer Footprint
  • New Clinical Data Validates Daxor's Blood Volume Analyzer as Uniquely Accurate
  • Daxor to Unveil Portable BVA at ACC.26, Citing 56% Readmission Drop & 82% Mortality Reduction

Financial Snapshot

Fiscal year ended December 31, 2011
Revenue
$1.45M
Net Income
-$7.19M
Op. Cash Flow
-$6.51M
Free Cash Flow
-$6.63M
Gross Profit
$793.83K
Operating Income
-$5.79M
Cash & Equivalents
$59.63K
Debt / Equity
0.00×
Net Margin
-496.8%
Shares Outstanding
4.2M sh
Source: 10-K · filed 2012-03-28 · accession 0001019056-12-000401
Browse all tickers starting with D →
$9.26
52-week range · as of 2026-05-21 $7.1 – $14.76
Market cap
$66.14M
Volume
1.3K (0.2× avg)
3-mo avg 7.1K
Live data · 2026-06-14 05:16 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DXR - Latest Insights

DXR
Jun 02, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $10.06
Real-time Price: $9.26 info
Change: -$0.800 (-8%) info
Market Cap: N/A info
DXR
May 21, 2026, 3:42 PM EDT
Filing Type: 40-8F-2/A
Importance Score:
8
Price at Filing: $10.82
Real-time Price: $9.26 info
Change: -$1.56 (-14%) info
Market Cap: N/A info
DXR
Apr 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $8.87
Real-time Price: $9.26 info
Change: +$0.390 (+4%) info
Market Cap: N/A info
DXR
Mar 26, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $10.23
Real-time Price: $9.26 info
Change: -$0.970 (-9%) info
Market Cap: N/A info
DXR
Mar 17, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $11.37
Real-time Price: $9.26 info
Change: -$2.11 (-19%) info
Market Cap: N/A info
DXR
Mar 03, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $11.50
Real-time Price: $9.26 info
Change: -$2.24 (-19%) info
Market Cap: N/A info
DXR
Feb 09, 2026, 4:01 PM EST
Filing Type: 40-8F-2
Importance Score:
8
Price at Filing: $12.25
Real-time Price: $9.26 info
Change: -$2.99 (-24%) info
Market Cap: N/A info
DXR
Jan 26, 2026, 4:58 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.28
Real-time Price: $9.26 info
Change: -$3.02 (-25%) info
Market Cap: N/A info
DXR
Jan 23, 2026, 9:24 PM EST
Filing Type: 424B4
Importance Score:
8
Price at Filing: $11.79
Real-time Price: $9.26 info
Change: -$2.53 (-21%) info
Market Cap: N/A info